Cellectis SA (CLLS)
2.72
+0.01
(+0.26%)
USD |
NASDAQ |
May 31, 16:00
2.71
-0.01
(-0.37%)
After-Hours: 20:00
Cellectis Accounts Payable (Quarterly): 16.05M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.05M |
December 31, 2023 | 19.07M |
September 30, 2023 | 20.48M |
June 30, 2023 | 19.23M |
March 31, 2023 | 22.32M |
December 31, 2022 | 21.46M |
September 30, 2022 | 22.35M |
June 30, 2022 | 24.16M |
March 31, 2022 | 20.92M |
December 31, 2021 | 23.76M |
September 30, 2021 | 22.81M |
June 30, 2021 | 28.25M |
March 31, 2021 | 24.68M |
December 31, 2020 | 24.61M |
September 30, 2020 | 35.00M |
June 30, 2020 | 32.67M |
March 31, 2020 | 26.87M |
December 31, 2019 | 29.26M |
September 30, 2019 | 19.76M |
June 30, 2019 | 19.76M |
March 31, 2019 | 15.70M |
December 31, 2018 | 15.88M |
September 30, 2018 | 15.60M |
June 30, 2018 | 12.73M |
March 31, 2018 | 11.25M |
Date | Value |
---|---|
December 31, 2017 | 9.46M |
September 30, 2017 | 12.69M |
June 30, 2017 | 17.20M |
March 31, 2017 | 13.01M |
December 31, 2016 | 9.722M |
September 30, 2016 | 10.29M |
June 30, 2016 | 12.60M |
March 31, 2016 | 8.967M |
December 31, 2015 | 7.228M |
September 30, 2015 | 7.500M |
June 30, 2015 | 5.998M |
March 31, 2015 | |
December 31, 2014 | 11.92M |
June 30, 2014 | 11.95M |
December 31, 2013 | 13.39M |
June 30, 2013 | 28.32M |
June 30, 2013 | 28.32M |
December 31, 2012 | 14.46M |
June 30, 2012 | 20.77M |
December 31, 2011 | 25.39M |
December 31, 2010 | 15.79M |
June 30, 2010 | 5.989M |
June 30, 2010 | 5.989M |
December 31, 2009 | 9.382M |
June 30, 2009 | 6.428M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
16.05M
Minimum
Mar 2024
35.00M
Maximum
Sep 2020
23.67M
Average
22.58M
Median
Accounts Payable (Quarterly) Benchmarks
DBV Technologies SA | 18.08M |
Genfit SA | 11.55M |
Biophytis SA | 5.960M |
Edap TMS SA | -- |
Adaptimmune Therapeutics PLC | 6.587M |